These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26288390)

  • 1. Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic Fibrosis.
    Sanders DB; Emerson J; Ren CL; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Ann Am Thorac Soc; 2015 Aug; 12(8):1170-6. PubMed ID: 26288390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcomes after initial pseudomonas acquisition in cystic fibrosis.
    Zemanick ET; Emerson J; Thompson V; McNamara S; Morgan W; Gibson RL; Rosenfeld M;
    Pediatr Pulmonol; 2015 Jan; 50(1):42-8. PubMed ID: 24644274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial.
    Saiman L; Marshall BC; Mayer-Hamblett N; Burns JL; Quittner AL; Cibene DA; Coquillette S; Fieberg AY; Accurso FJ; Campbell PW;
    JAMA; 2003 Oct; 290(13):1749-56. PubMed ID: 14519709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the associations between lung function and clinical features in preschool children with cystic fibrosis.
    Ren CL; Rosenfeld M; Mayer OH; Davis SD; Kloster M; Castile RG; Hiatt PW; Hart M; Johnson R; Jones P; Brumback LC; Kerby GS
    Pediatr Pulmonol; 2012 Jun; 47(6):574-81. PubMed ID: 22081584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline characteristics and factors associated with nutritional and pulmonary status at enrollment in the cystic fibrosis EPIC observational cohort.
    Rosenfeld M; Emerson J; McNamara S; Joubran K; Retsch-Bogart G; Graff GR; Gutierrez HH; Kanga JF; Lahiri T; Noyes B; Ramsey B; Ren CL; Schechter M; Morgan W; Gibson RL;
    Pediatr Pulmonol; 2010 Sep; 45(9):934-44. PubMed ID: 20597081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early respiratory infection is associated with reduced spirometry in children with cystic fibrosis.
    Ramsey KA; Ranganathan S; Park J; Skoric B; Adams AM; Simpson SJ; Robins-Browne RM; Franklin PJ; de Klerk NH; Sly PD; Stick SM; Hall GL;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1111-6. PubMed ID: 25321321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiectases at early chest computed tomography in children with cystic fibrosis are associated with increased risk of subsequent pulmonary exacerbations and chronic pseudomonas infection.
    Bortoluzzi CF; Volpi S; D'Orazio C; Tiddens HA; Loeve M; Tridello G; Assael BM
    J Cyst Fibros; 2014 Sep; 13(5):564-71. PubMed ID: 24726420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for mortality before age 18 years in cystic fibrosis.
    McColley SA; Schechter MS; Morgan WJ; Pasta DJ; Craib ML; Konstan MW
    Pediatr Pulmonol; 2017 Jul; 52(7):909-915. PubMed ID: 28436621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early childhood wheezing is associated with lower lung function in cystic fibrosis.
    Ren CL; Konstan MW; Rosenfeld M; Pasta DJ; Millar SJ; Morgan WJ;
    Pediatr Pulmonol; 2014 Aug; 49(8):745-50. PubMed ID: 24123917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
    Cogen J; Emerson J; Sanders DB; Ren C; Schechter MS; Gibson RL; Morgan W; Rosenfeld M;
    Pediatr Pulmonol; 2015 Aug; 50(8):763-70. PubMed ID: 26061914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary exacerbations and clinical outcomes in a longitudinal cohort of infants and preschool children with cystic fibrosis.
    Hoppe JE; Wagner BD; Sagel SD; Accurso FJ; Zemanick ET
    BMC Pulm Med; 2017 Dec; 17(1):188. PubMed ID: 29228933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.
    Pittman JE; Noah H; Calloway HE; Davis SD; Leigh MW; Drumm M; Sagel SD; Accurso FJ; Knowles MR; Sontag MK
    PLoS One; 2017; 12(5):e0177215. PubMed ID: 28505188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Life Growth Trajectories in Cystic Fibrosis are Associated with Pulmonary Function at Age 6 Years.
    Sanders DB; Fink A; Mayer-Hamblett N; Schechter MS; Sawicki GS; Rosenfeld M; Flume PA; Morgan WJ
    J Pediatr; 2015 Nov; 167(5):1081-8.e1. PubMed ID: 26340874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomonas aeruginosa in cystic fibrosis patients with G551D-CFTR treated with ivacaftor.
    Heltshe SL; Mayer-Hamblett N; Burns JL; Khan U; Baines A; Ramsey BW; Rowe SM;
    Clin Infect Dis; 2015 Mar; 60(5):703-12. PubMed ID: 25425629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Kotnik Pirš A; Krivec U; Simčič S; Seme K
    BMC Pulm Med; 2016 Nov; 16(1):161. PubMed ID: 27884144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between Chronic Rhinosinusitis and Health-Related Quality of Life in Adults with Cystic Fibrosis.
    Habib AR; Buxton JA; Singer J; Wilcox PG; Javer AR; Quon BS
    Ann Am Thorac Soc; 2015 Aug; 12(8):1163-9. PubMed ID: 26011015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis.
    Ong T; Schechter M; Yang J; Peng L; Emerson J; Gibson RL; Morgan W; Rosenfeld M;
    Pediatrics; 2017 Feb; 139(2):. PubMed ID: 28093464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
    Regelmann WE; Schechter MS; Wagener JS; Morgan WJ; Pasta DJ; Elkin EP; Konstan MW;
    Pediatr Pulmonol; 2013 Jul; 48(7):649-57. PubMed ID: 22949088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lung disease progression in children with cystic fibrosis.
    van Horck M; van de Kant K; Winkens B; Wesseling G; Gulmans V; Hendriks H; van der Grinten C; Jöbsis Q; Dompeling E
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29773689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.